These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 15215134)
1. In vitro activities of a novel cephalosporin, CB-181963 (CAB-175), against methicillin-susceptible or -resistant Staphylococcus aureus and glycopeptide-intermediate susceptible staphylococci. Huang V; Brown WJ; Rybak MJ Antimicrob Agents Chemother; 2004 Jul; 48(7):2719-23. PubMed ID: 15215134 [TBL] [Abstract][Full Text] [Related]
2. Comparative activity of the new lipoglycopeptide telavancin in the presence and absence of serum against 50 glycopeptide non-susceptible staphylococci and three vancomycin-resistant Staphylococcus aureus. Leuthner KD; Cheung CM; Rybak MJ J Antimicrob Chemother; 2006 Aug; 58(2):338-43. PubMed ID: 16787952 [TBL] [Abstract][Full Text] [Related]
3. Antistaphylococcal activity of CB-181963 (CAB-175), an experimental parenteral cephalosporin. Hoellman DB; Pankuch GA; Appelbaum PC Antimicrob Agents Chemother; 2004 Oct; 48(10):4037-9. PubMed ID: 15388474 [TBL] [Abstract][Full Text] [Related]
4. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model. Zhanel GG; Voth D; Nichol K; Karlowsky JA; Noreddin AM; Hoban DJ J Antimicrob Chemother; 2009 Aug; 64(2):364-9. PubMed ID: 19454524 [TBL] [Abstract][Full Text] [Related]
5. In vitro activity of the new multivalent glycopeptide-cephalosporin antibiotic TD-1792 against vancomycin-nonsusceptible Staphylococcus isolates. Leuthner KD; Vidaillac C; Cheung CM; Rybak MJ Antimicrob Agents Chemother; 2010 Sep; 54(9):3799-803. PubMed ID: 20585126 [TBL] [Abstract][Full Text] [Related]
6. Antistaphylococcal activity of the novel cephalosporin CB-181963 (CAB-175). Miller K; Storey C; Stubbings WJ; Hoyle AM; Hobbs JK; Chopra I J Antimicrob Chemother; 2005 Apr; 55(4):579-82. PubMed ID: 15722396 [TBL] [Abstract][Full Text] [Related]
7. In vitro activity of linezolid & quinupristin/dalfopristin against Gram-positive cocci. Tünger A; Aydemir S; Uluer S; Cilli F Indian J Med Res; 2004 Dec; 120(6):546-52. PubMed ID: 15654141 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of the extracellular and intracellular activities (human THP-1 macrophages) of telavancin versus vancomycin against methicillin-susceptible, methicillin-resistant, vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus. Barcia-Macay M; Lemaire S; Mingeot-Leclercq MP; Tulkens PM; Van Bambeke F J Antimicrob Chemother; 2006 Dec; 58(6):1177-84. PubMed ID: 17062609 [TBL] [Abstract][Full Text] [Related]
9. A comparative in-vitro evaluation of resistance selection after exposure to teicoplanin, vancomycin, linezolid and quinupristin-dalfopristin in Staphylococcus aureus and Enterococcus spp. Drago L; Nicola L; De Vecchi E Clin Microbiol Infect; 2008 Jun; 14(6):608-11. PubMed ID: 18397336 [TBL] [Abstract][Full Text] [Related]
10. Comparative activities of daptomycin and several agents against staphylococcal blood isolates. Glycopeptide tolerance. Picazo JJ; Betriu C; Rodríguez-Avial I; Culebras E; López-Fabal F; Gómez M; Diagn Microbiol Infect Dis; 2011 Jul; 70(3):373-9. PubMed ID: 21683269 [TBL] [Abstract][Full Text] [Related]
11. In vitro activity of nemonoxacin (TG-873870), a novel non-fluorinated quinolone, against clinical isolates of Staphylococcus aureus, enterococci and Streptococcus pneumoniae with various resistance phenotypes in Taiwan. Chen YH; Liu CY; Lu JJ; King CH; Hsueh PR J Antimicrob Chemother; 2009 Dec; 64(6):1226-9. PubMed ID: 19833635 [TBL] [Abstract][Full Text] [Related]
12. Activity of quinupristin/dalfopristin against extracellular and intracellular Staphylococcus aureus with various resistance phenotypes. Baudoux P; Lemaire S; Denis O; Tulkens PM; Van Bambeke F; Glupczynski Y J Antimicrob Chemother; 2010 Jun; 65(6):1228-36. PubMed ID: 20378672 [TBL] [Abstract][Full Text] [Related]
13. Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05. Steinkraus G; White R; Friedrich L J Antimicrob Chemother; 2007 Oct; 60(4):788-94. PubMed ID: 17623693 [TBL] [Abstract][Full Text] [Related]
14. In vitro activities of quinupristin-dalfopristin and cefepime, alone and in combination with various antimicrobials, against multidrug-resistant staphylococci and enterococci in an in vitro pharmacodynamic model. Allen GP; Cha R; Rybak MJ Antimicrob Agents Chemother; 2002 Aug; 46(8):2606-12. PubMed ID: 12121940 [TBL] [Abstract][Full Text] [Related]
15. Comparative bactericidal activities of daptomycin, glycopeptides, linezolid and tigecycline against blood isolates of Gram-positive bacteria in Taiwan. Huang YT; Liao CH; Teng LJ; Hsueh PR Clin Microbiol Infect; 2008 Feb; 14(2):124-9. PubMed ID: 18076671 [TBL] [Abstract][Full Text] [Related]
16. Linezolid and quinupristin/dalfopristin resistance in vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus prior to clinical use in Turkey. Baysallar M; Kilic A; Aydogan H; Cilli F; Doganci L Int J Antimicrob Agents; 2004 May; 23(5):510-2. PubMed ID: 15120733 [TBL] [Abstract][Full Text] [Related]
17. In vitro antistaphylococcal activity of dalbavancin, a novel glycopeptide. Lopez S; Hackbarth C; Romanò G; Trias J; Jabes D; Goldstein BP J Antimicrob Chemother; 2005 Mar; 55 Suppl 2():ii21-4. PubMed ID: 15750033 [TBL] [Abstract][Full Text] [Related]
18. In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model. Jacqueline C; Caillon J; Le Mabecque V; Miègeville AF; Hamel A; Bugnon D; Ge JY; Potel G Antimicrob Agents Chemother; 2007 Sep; 51(9):3397-400. PubMed ID: 17591849 [TBL] [Abstract][Full Text] [Related]
19. MRSA--the tip of the iceberg. Appelbaum PC Clin Microbiol Infect; 2006 Apr; 12 Suppl 2():3-10. PubMed ID: 16524422 [TBL] [Abstract][Full Text] [Related]